http://sdbn.org sdbn.org Thu, 11 Mar 2010 21:38:26 +0000 http://backend.userland.com/rss092 en A few years ago, news articles in Business Week, Nature, and elsewhere described a veritable stampede among big pharmaceutical companies like Roche, Eli Lilly, Pfizer, and GlaxoSmithKline to work... [[Click headline to continue reading.]] http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/JV4UzTECnBc/ Things were hopping over the past week in San Diego. Get into the rhythm here. —San Diego’s West Wireless Health Institute named Donald Casey chief executive officer. Casey was formerly... [[Click headline to continue reading.]] http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/ug5V4F66wRA/ SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it has sequenced the DNA of American actress Glenn Close, the first publicly named female to have her DNA sequenced to full coverage. The service was completed in Illuminas CLIA certified and CAP accredited laboratory utilizing Illuminas Genome Analyzer technology and following ... http://www.biospace.com/news_story.aspx?StoryID=173637&full=1 LOS ANGELES--(BUSINESS WIRE)--Abraxis BioScience, Inc. (NASDAQ: ABII), a fully integrated biotechnology company, today reported financial results for the fourth quarter and full year ended December 31, 2009. http://www.biospace.com/news_story.aspx?StoryID=173618&full=1 SAN DIEGO--(BUSINESS WIRE)--March 11, 2010--Senomyx, Inc. (NASDAQ: SNMX), a leading company focused on using proprietary taste receptor technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that Kent Snyder, the Companys Chief Executive Officer, will present a corporate overview on Tuesday, ... http://www.biospace.com/news_story.aspx?StoryID=173612&full=1 SAN DIEGO, March 10 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Roth 22nd Annual OC Growth Conference in Laguna Niguel. If you are unable to attend the webcast and would like further information ... http://www.biospace.com/news_story.aspx?StoryID=173619&full=1 IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a commercial-stage biotechnology company with a focus in oncology, announced today that an overview of the Companys business strategy will be given at the 22nd Annual ROTH Capital Markets Conference on Monday, March 15, 2010, at 8:00 am Pacific Time. The conference is being ... http://www.biospace.com/news_story.aspx?StoryID=173635&full=1 CARLSBAD, Calif.--(BUSINESS WIRE)--Scientists using advanced genomic analysis technologies from Life Technologies Corporation (NASDAQ: LIFE) have sequenced an individuals genome and identified the specific causative mutation associated with Charcot-Marie-Tooth Disease (CMT), one of the most common inherited neurological disorders currently affecting 1 in 2,500 individuals in the United States. http://www.biospace.com/news_story.aspx?StoryID=173647&full=1 Acadia Pharmaceuticals of San Diego and its Canadian partner Biovail are continuing to move ahead with pimavanserin. The experimental drug, you might recall, failed last September in a trial testing... [[Click headline to continue reading.]] http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/M2yENqA6xWs/ It’s pins-and-needles time for employees and investors at San Diego-based Amylin Pharmaceuticals and Waltham, MA-based Alkermes. The FDA has a deadline of Friday, March 12, to say whether it... [[Click headline to continue reading.]] http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/lxUajn7b8p0/